WT1 peptide cancer vaccine composition for transdermal administration
US10071051B2 · kind B2 · utility
2Cited by
1References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 29, 2014 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | Jan 29, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a cancer vaccine composition for transdermal administration for cellular immunity induction, comprising (i) a WT1 peptide and/or a modified WT1 peptide; and (ii) a pharmacologically acceptable acid as a first cellular immunity induction promoter, or a pharmacologically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.